
AI-generated summary
The National Health Commission, the National Medical Insurance Administration, the State Administration of Traditional Chinese Medicine, and the State Administration of Disease Control and Prevention jointly issued the "Notice on Further Improving the Safe and Rational Distribution and Use of Innovative Drugs", proposing specific policies and measures around promoting rational distribution, strengthening training and guidance, optimizing conditions for use, and improving management measures.
The National Health Commission, the National Medical Insurance Administration, the State Administration of Traditional Chinese Medicine, and the State Administration of Disease Control and Prevention issued the "Notice on Further Improving the Safe and Rational Distribution and Use of Innovative Drugs" today (10th). Focusing on the key aspects of the safe and rational distribution and use of innovative drugs, specific policies and measures were proposed in terms of promoting rational distribution, strengthening training and guidance, optimizing use conditions, and improving management measures.
First, medical institutions at level 2 and above are required to optimize and improve the admission system and work process of innovative drugs, hold timely meetings of the Pharmacy Management and Therapeutics Committee, and timely include innovative drugs in the institution's drug catalog based on business capabilities and diagnosis and treatment needs. Promote provincial and municipal hospitals to play a leading role step by step.
The second is to require regular organization and training of medication knowledge and medical insurance payment policies. Timely compile and publish expert consensus on the clinical use of innovative drugs, and timely incorporate drugs with sufficient evidence-based medicine into clinical diagnosis and treatment guidelines.
The third is to implement pharmaceutical-related medical service price items, further improve support and guarantee measures, and optimize the policy environment for the use of innovative drugs.
The fourth is to emphasize that there will be no restrictions on the number of total drug varieties and regulations in medical institutions, and it will be clarified that relevant innovative drugs will not be included in the performance monitoring indicators of public medical institutions such as the increase in the average outpatient drug cost and the increase in the average inpatient drug cost.
(CCTV reporters Wen Yongyi and Shi Yingchun)

The U.S. FDA requires GLP-1 weight loss and diabetes drugs such as Trixan and Mengena to add warnings on the package labels, reminding them that they may increase the risk of non-arteritic anterior ischemic optic neuropathy (NAION), which may lead to sudden vision loss or even permanent damage. Eli Lilly and Novo Nordisk responded respectively. Citi analysts believe that concerns may be deepened in the short term, but the impact on prescriptions will be limited.

Baylor College of Medicine, Houston Methodist Hospital and other institutions analyzed data from nearly 3.495 million American men and found that erectile dysfunction is associated with a higher risk of cardiovascular disease. The risk ratio for men aged 41 to 50 was 2.54, but retrospective studies cannot prove causality.
On the eve of the 15th International Radiation Day, China's medical teams in Guyana and Zanzibar conducted special training on radiology imaging in Georgetown and Zanzibar. More than 60 people from the three places participated, covering MRI, X-ray, CT applications and image quality control. Traditional Chinese medicine lectures and Chinese food demonstrations were also held simultaneously.

The Food and Drug Administration announced border inspection violations, including violations of dioxin levels in China's mitten crabs, banned pesticides in Indonesian green coffee beans, and imported products from Teddi Lab and Taiwan's Smail Food containing non-permitted sweeteners. Related products need to be returned or destroyed.

The Special Fund for Health Communication and Promotion of the China Health Promotion Foundation jointly released the "Painless China·Core Tips for Common Pain Response (2026)", which proposes scientific response strategies, standardized use of analgesics, and recommendations on the timing of medical treatment for seven types of common pain: neck, shoulder, lower back pain, tendon sheath strain, osteoarthritis, sports injury, dysmenorrhea, headache, and toothache, to help the public correctly understand and scientifically manage pain.

Under the temptation of Double 11 shopping festival promotions, people are prone to fall into a vicious cycle of impulsive consumption. He Yifeng, director of the psychiatry department at Caotun Sanatorium of the Ministry of Health and Welfare, pointed out that the dopamine pleasure brought by shopping is short-lived and is often followed by anxiety and guilt, which may seriously evolve into compulsive shopping disorder. He suggested adopting three psychological hemostasis methods before checking out: "clarify your emotions, delay gratification for 72 hours, and control your entertainment consumption budget" and cultivate diverse interests to regulate your emotions.